References
H. Chen, Y. Pang, J. Wu, L. Zhao, B. Hao, J. Wu, J. Wei, S. Wu, L. Zhao, Z. Luo, X. Lin, C. Xie, L. Sun, Q. Lin, H. Wu, Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer. Eur. J. Nuc. Med. Mol. Imaging 47(8), 1820–1832 (2020)
C. Kratochwil, P. Flechsig, T. Lindner, L. Abderrahim, A. Altmann, W. Mier, S. Adeberg, H. Rathke, M. Rohrich, H. Winter, P.K. Plinkert, F. Marme, M. Lang, H.U. Kauczor, D. Jager, J. Debus, U. Haberkorn, F.L. Giesel, (68)Ga-FAPI PET/CT: tracer uptake in 28 different kinds of cancer. J. Nucl. Med 60(6), 801–805 (2019)
R. J. Hicks, P. J. Roselt, K. G. Kallur, R. W. Tothill, L. Mileshkin, State-of-the-art: FAPI PET/CT-will it end the hegemony of FDG in oncology. J. Nucl. Med. 62(3), 296–302 (2021)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Informed consent and ethical approval
This study was approved by the institutional review board in our institution and written informed consent for publication of this report was obtained from the patient.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Wu, J., Ou, L. & Zhang, C. Comparison of 68Ga-FAPI and 18F-FDG PET/CT in metastases of papillary thyroid carcinoma. Endocrine 73, 767–768 (2021). https://doi.org/10.1007/s12020-021-02668-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-021-02668-3